XOMA 129
XOMA 129 is a human monoclonal antibody targeting INSR. XOMA 129 is an insulin receptor (IR) antagonist that inhibits the drop in blood glucose. XOMA 129 can be used in the study of hypoglycemia [1].
Product Specifications
UNSPSC
12352203
Target
Insulin Receptor
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Endocrinology
Smiles
[XOMA129]
References & Citations
[1]Li O, et al. XOMA 129, a Novel Insulin Receptor Negative Modulator, Is Efficacious in Treating Insulin-Induced Hypoglycemia in Minipigs[J]. Blood, 2017, 200 (100) : 0.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
